Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer

被引:42
作者
Xu, Shan [1 ]
Yang, Ya'nan [1 ]
Dong, Lingling [2 ]
Qiu, Wenlong [3 ]
Yang, Lu [1 ]
Wang, Xiuwen [1 ]
Liu, Lian [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Ctr Canc, Dept Chemotherapy, Jinan 250100, Peoples R China
[2] Weifang Tradit Chinese Med Hosp, Dept Canc, Weifang, Peoples R China
[3] Shandong Univ, Dept Med, Sch Med, Jinan 250100, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
OVARIAN CANCER; ONCOGENESIS; CELL-CELL ADHESION; ANOIKIS RESISTANCE; SURFACE EPITHELIUM; EXPRESSION; ACTIVATION; SURVIVAL; SPHEROIDS; COMPLEX; ACQUISITION; INTEGRINS;
D O I
10.1038/srep05646
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ovarian cancer is the deadliest of all gynecologic malignancies. Metastatic ovarian cancer cells exist mainly in the form of multi-cellular spheroids (MCSs) in the ascites of patients with advanced ovarian cancer. We hypothesized that E-cadherin, as an important cell-adhesion molecule, might play an important role in the formation and survival of MCSs. Therefore, we established a three-dimensional suspension culture model of ovarian cancer cells that express high levels of E-cadherin to investigate their growth, proliferation, and resistance to chemotherapeutic drugs by CCK-8 assays. Compared to the cell suspension masses formed by cells with low or absent E-cadherin expression, the MCSs of high E-cadherin SKOV-3 cells had larger volumes, tighter cellular connections, and longer survival times. Although the suspension cell masses of all three cell lines were proliferatively stagnant, possibly due to cell cycle arrest at G1/S, cell mortality at 72 h after cisplatin treatment was significantly decreased in the high E-cadherin SKOV-3 cells compared to SKOV-3 cells without E-cadherin expression and to OVCAR-3 cells with low E-cadherin expression. We conclude, therefore, E-cadherin plays a vital role in MCS formation, maintenance, and drug resistance in ovarian cancer and could be a potential target for late-stage ovarian cancer treatment.
引用
收藏
页数:8
相关论文
共 49 条
[1]   Pattern and prognostic factors in patients with malignant ascites: a retrospective study [J].
Ayantunde, A. A. ;
Parsons, S. L. .
ANNALS OF ONCOLOGY, 2007, 18 (05) :945-949
[2]   The biology of ovarian cancer: new opportunities for translation [J].
Bast, Robert C., Jr. ;
Hennessy, Bryan ;
Mills, Gordon B. .
NATURE REVIEWS CANCER, 2009, 9 (06) :415-428
[3]   The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression [J].
Berx, G ;
Van Roy, F .
BREAST CANCER RESEARCH, 2001, 3 (05) :289-293
[4]   E-CADHERIN AS A TUMOR (INVASION) SUPPRESSOR GENE [J].
BIRCHMEIER, W .
BIOESSAYS, 1995, 17 (02) :97-99
[5]   Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids [J].
Carduner, Ludovic ;
Picot, Cedric R. ;
Leroy-Dudal, Johanne ;
Blay, Lyvia ;
Kellouche, Sabrina ;
Carreiras, Franck .
EXPERIMENTAL CELL RESEARCH, 2014, 320 (02) :329-342
[6]   β1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids [J].
Casey, RC ;
Burleson, KM ;
Skubitz, KM ;
Pambuccian, SE ;
Oegema, TR ;
Ruff, LE ;
Skubitz, APN .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (06) :2071-2080
[7]   Cell adhesion and signalling by cadherins and Ig-CAMs in cancer [J].
Cavallaro, U ;
Christofori, G .
NATURE REVIEWS CANCER, 2004, 4 (02) :118-132
[8]   Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinicopathologic study of 60 cases [J].
Darai, E ;
Scoazec, JY ;
WalkerCombrouze, F ;
MlikaCabanne, N ;
Feldmann, G ;
Madelenat, P ;
Potet, F .
HUMAN PATHOLOGY, 1997, 28 (08) :922-928
[9]   E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells [J].
De Santis, G. ;
Miotti, S. ;
Mazzi, M. ;
Canevari, S. ;
Tomassetti, A. .
ONCOGENE, 2009, 28 (09) :1206-1217
[10]   Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents -: art. no. 39 [J].
Díaz-Montero, CM ;
McIntyre, BW .
BMC CANCER, 2005, 5 (1)